1430 related articles for article (PubMed ID: 30616998)
1. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study.
Justice JN; Nambiar AM; Tchkonia T; LeBrasseur NK; Pascual R; Hashmi SK; Prata L; Masternak MM; Kritchevsky SB; Musi N; Kirkland JL
EBioMedicine; 2019 Feb; 40():554-563. PubMed ID: 30616998
[TBL] [Abstract][Full Text] [Related]
2. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
3. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.
Nambiar A; Kellogg D; Justice J; Goros M; Gelfond J; Pascual R; Hashmi S; Masternak M; Prata L; LeBrasseur N; Limper A; Kritchevsky S; Musi N; Tchkonia T; Kirkland J
EBioMedicine; 2023 Apr; 90():104481. PubMed ID: 36857968
[TBL] [Abstract][Full Text] [Related]
4. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
[TBL] [Abstract][Full Text] [Related]
5. Cellular Senescence in Idiopathic Pulmonary Fibrosis.
Kellogg DL; Kellogg DL; Musi N; Nambiar AM
Curr Mol Biol Rep; 2021; 7(3):31-40. PubMed ID: 34401216
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitors as senolytic drugs to extend healthy aging.
Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD
Cell Cycle; 2018; 17(9):1048-1055. PubMed ID: 29886783
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence mediates fibrotic pulmonary disease.
Schafer MJ; White TA; Iijima K; Haak AJ; Ligresti G; Atkinson EJ; Oberg AL; Birch J; Salmonowicz H; Zhu Y; Mazula DL; Brooks RW; Fuhrmann-Stroissnigg H; Pirtskhalava T; Prakash YS; Tchkonia T; Robbins PD; Aubry MC; Passos JF; Kirkland JL; Tschumperlin DJ; Kita H; LeBrasseur NK
Nat Commun; 2017 Feb; 8():14532. PubMed ID: 28230051
[TBL] [Abstract][Full Text] [Related]
8. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome.
Tanaka T; Urata Y; Harada M; Kunitomi C; Kusamoto A; Koike H; Xu Z; Sakaguchi N; Tsuchida C; Komura A; Teshima A; Takahashi N; Wada-Hiraike O; Hirota Y; Osuga Y
Mol Hum Reprod; 2024 Apr; 30(5):. PubMed ID: 38603629
[TBL] [Abstract][Full Text] [Related]
10. Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?
Cazzola M; Matera MG; Rogliani P; Calzetta L
Expert Opin Investig Drugs; 2018 Jul; 27(7):573-581. PubMed ID: 29972333
[TBL] [Abstract][Full Text] [Related]
11. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
[TBL] [Abstract][Full Text] [Related]
12. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
[TBL] [Abstract][Full Text] [Related]
13. Senolytic drugs: from discovery to translation.
Kirkland JL; Tchkonia T
J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
[TBL] [Abstract][Full Text] [Related]
14. Senolytics Cocktail Dasatinib and Quercetin Alleviate Human Umbilical Vein Endothelial Cell Senescence via the TRAF6-MAPK-NF-κB Axis in a YTHDF2-Dependent Manner.
Fan T; Du Y; Zhang M; Zhu AR; Zhang J
Gerontology; 2022; 68(8):920-934. PubMed ID: 35468611
[TBL] [Abstract][Full Text] [Related]
15. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
16. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
Gao Y; Wu T; Tang X; Wen J; Zhang Y; Zhang J; Wang S
Geroscience; 2023 Jun; 45(3):1775-1790. PubMed ID: 36648735
[TBL] [Abstract][Full Text] [Related]
17. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
Merkt W; Bueno M; Mora AL; Lagares D
Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
[TBL] [Abstract][Full Text] [Related]
18. Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial.
Gonzales MM; Garbarino VR; Marques Zilli E; Petersen RC; Kirkland JL; Tchkonia T; Musi N; Seshadri S; Craft S; Orr ME
J Prev Alzheimers Dis; 2022; 9(1):22-29. PubMed ID: 35098970
[TBL] [Abstract][Full Text] [Related]
19. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
[TBL] [Abstract][Full Text] [Related]
20. Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells.
Zhang X; Dong Y; Li WC; Tang BX; Li J; Zang Y
Acta Pharmacol Sin; 2021 Dec; 42(12):2058-2068. PubMed ID: 33654217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
